Mode
Text Size
Log in / Sign up

Observational biobank study compares phenomic and social determinants for disease risk predictionYour Genes Aren’t Your Destiny: How Your Neighborhood Changes Your Risk

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that phenomic PGS and social determinants can refine risk prediction, but findings are observational and disease-specific.

This research article presents an observational analysis from UK Biobank, Mass General Brigham Biobank, and All of Us participants. It evaluates phenome-derived polygenic scores (PGS) for 35 latent phenomic factors and social determinants of health (SDoH) for predicting asthma, coronary artery disease, and type 2 diabetes, compared to conventional disease-specific PGS.

For asthma prediction, factor-based PGS outperformed disease-specific PGS and showed superior cross-ancestry portability. Specifically, the respiratory factor PGS retained 41.5% of European-ancestry predictive accuracy in African-ancestry individuals, compared with 22.9% for asthma PGS from multi-ancestry GWAS. For coronary artery disease and type 2 diabetes, disease-specific PGS remained superior. SDoH contributed substantial and largely independent predictive information across all three diseases.

The authors note that genetic liability translation was modified by SDoH; for asthma and CAD, genetic stratification attenuated with increasing social burden, with weaker attenuation for T2D. Key limitations include that predictive utility is strongly disease dependent and findings are based on observational biobank data. Practice relevance suggests phenome-derived PGS may improve prediction when disease-specific GWAS incompletely capture underlying liability, and SDoH independently modifies genetic risk performance.

Imagine you have a family history of heart disease. You might worry that your genes seal your fate. But what if your daily life—where you live, what you eat, and your stress levels—could change that outcome? A new study reveals that your health is not just about your DNA, but how your DNA interacts with the world around you.

This changes how we think about genetic testing and personal health.

Why Your Genes Tell Only Half the Story

Most of us think of diseases as separate boxes. There’s a box for asthma, a box for heart disease, and a box for diabetes. For years, genetic research has tried to find the specific genes for each box. But our bodies are more connected than that.

Many diseases share common genetic roots. For example, the same genetic factors might influence both heart health and inflammation. This study, published in medRxiv, looked at this bigger picture. Instead of focusing on one disease at a time, researchers analyzed thousands of health traits together to find hidden patterns.

This approach is crucial because it’s more realistic. Our bodies are complex systems, not a collection of separate parts. Understanding this shared genetic liability helps us see a more accurate health map.

The Old Way vs. The New Way

Traditionally, scientists create a "polygenic score" (PGS) for a single disease. This score estimates your risk based on thousands of small genetic changes linked to that one condition. It’s like having a separate key for each door in your house.

But what if many doors are made from the same wood? The new method creates scores based on "latent phenomic factors"—hidden patterns that connect many different health traits. Instead of one key per door, you get a master key that understands the building’s structure.

Here’s the twist: this master key isn’t always better. The study found that for some diseases, the old single-disease score still works best. But for others, especially where the disease is complex or poorly defined, the new factor-based score is a big improvement.

Think of your genetic risk like a traffic jam. A single-disease score looks for the specific cars causing a blockage on one road. The new factor-based score looks at the entire traffic system—weather, road construction, and driver behavior—to understand why jams happen in general.

The researchers built 35 different "master keys" based on thousands of health traits from over 360,000 people in the UK Biobank. Each key represents a hidden biological pattern, like "respiratory health" or "metabolic function."

They then tested these keys in other large groups, including people from the Mass General Brigham Biobank and the All of Us Research Program. The goal was to see if these new scores could predict disease risk better than the old ones, especially for people from different ancestral backgrounds.

A Closer Look at the Study

The study used data from three major biobanks. First, they created the new factor-based scores using the UK Biobank. Then, they tested how well these scores predicted asthma, coronary artery disease (CAD), and type 2 diabetes (T2D) in new groups.

They also looked at social determinants of health (SDoH)—factors like income, education, and neighborhood. This is a key part of the study. It’s not just about your genes; it’s about the environment those genes live in.

The Results: A Clear Win for Asthma

For asthma, the new "respiratory factor" score was a clear winner. It predicted asthma risk better than the old disease-specific score. More importantly, it worked well across different ancestries.

In people of African ancestry, the new score kept 41.5% of its predictive power compared to European ancestry. The old asthma score only kept 22.9%. This is a huge step forward for making genetic medicine more equitable.

But for heart disease and type 2 diabetes, the old disease-specific scores were still better. This tells us that the new method isn't a magic bullet. It works best when the disease is biologically complex or when the traditional genetic studies have missed something.

This doesn’t mean this treatment is available yet.

The Surprising Power of Your Environment

Here’s where the study gets really interesting. The researchers found that your social environment changes how your genes affect your health.

For asthma and heart disease, as social burden increased (like living in a neighborhood with fewer resources), the genetic risk became less important. In other words, a tough environment can overshadow your genes. For type 2 diabetes, this effect was weaker, meaning genes played a more consistent role regardless of social factors.

This shows that the same genetic risk score can mean different things for different people. A high genetic risk for heart disease might be manageable in a supportive environment but much more dangerous in a stressful one.

What Experts Are Saying

While the study doesn’t include direct expert quotes, its findings align with a growing movement in medicine: precision public health. This means tailoring health strategies not just to your biology, but also to your life circumstances. The study suggests that future genetic risk tools must include social factors to be truly accurate.

Right now, this research is still in the lab. You can’t get a "phenome-derived" score from your doctor. But it points to a future where your genetic risk report is more nuanced.

If you have a family history of disease, this study is a reminder to look at the whole picture. Talk to your doctor about both your genetic risks and your lifestyle factors. The best prevention plan will address both.

This research is based on data from large biobanks, which may not represent everyone. The findings are also early-stage and need to be validated in more diverse populations. Most importantly, these scores are not yet ready for clinical use.

Next, researchers will need to test these factor-based scores in even larger and more diverse groups. They will also need to see if using these scores actually improves patient outcomes in real-world clinics. If successful, this could lead to a new generation of genetic risk tools that are fairer and more accurate for everyone.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Polygenic scores (PGS) are typically derived from single-trait genome-wide association studies (GWAS), yet many complex diseases arise from shared genetic liability distributed across correlated clinical dimensions. Accordingly, disease risk depends not only on how genetic liability is represented but also on the social context in which that liability is expressed. Whether phenome-derived latent factors improve prediction, and how social determinants of health (SDoH) modify the realized utility of PGS, remains unclear. Here we constructed PGS for 35 orthogonal latent phenomic factors derived from 2,772 phenotypes in 361,114 UK Biobank (UKB) participants and evaluated their phenomic specificity, cross-dataset portability and predictive performance relative to conventional disease-specific PGS across the UKB holdout, Mass General Brigham Biobank and the All of Us (AoU) Research Program. Factor-based PGS showed widespread, biologically coherent phenome-wide associations that were reproducible across biobanks and ancestries. Their predictive utility, however, was strongly disease dependent. For asthma, a respiratory factor PGS outperformed an internally derived disease-specific PGS and showed superior cross-ancestry portability, retaining 41.5% of European-ancestry predictive accuracy in African-ancestry individuals, compared with 22.9% for an asthma PGS derived from the largest available multi-ancestry GWAS. By contrast, disease-specific PGS remained superior for coronary artery disease (CAD) and type 2 diabetes (T2D). These findings suggest that phenome-derived aggregation is most beneficial when disease-specific GWAS incompletely capture underlying liability, including settings of biological heterogeneity or imprecise phenotyping. We then evaluated SDoH in AoU as a complementary axis shaping prevalent disease prediction beyond genetic susceptibility. Across all three diseases, SDoH contributed substantial and largely independent predictive information beyond the disease-optimal genetic model. SDoH also modified how genetic liability translated into observed disease prevalence: for asthma and CAD, genetic stratification attenuated with increasing social burden, whereas this attenuation was substantially weaker for T2D. As a result, the same genetic percentile corresponded to different standardized predicted prevalences across social strata, reflecting disease-specific shifts in baseline prevalence, genetic gradients and calibration. Together, these findings indicate that disease risk is shaped by both genetic liability and the social context in which that liability is realized. Phenome-derived PGS improve prediction under specific architectural conditions, whereas social context independently modifies the performance, calibration and interpretation of genetic risk across populations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.